TMDX
Income statement / Annual
Last year (2023), TransMedics Group, Inc.'s total revenue was $241.62 M,
an increase of 158.53% from the previous year.
In 2023, TransMedics Group, Inc.'s net income was -$25.03 M.
See TransMedics Group, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/28/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$241.62 M
|
$93.46 M
|
$30.26 M
|
$25.64 M
|
$23.60 M
|
$13.02 M
|
$7.69 M
|
$6.21 M
|
| Cost of Revenue |
$87.53 M |
$28.19 M |
$9.10 M |
$9.00 M |
$9.74 M |
$7.28 M |
$5.55 M |
$5.44 M |
| Gross Profit |
$154.09 M |
$65.27 M |
$21.16 M |
$16.64 M |
$13.86 M |
$5.73 M |
$2.14 M |
$766,000.00 |
| Gross Profit Ratio |
0.64 |
0.7 |
0.7 |
0.65 |
0.59 |
0.44 |
0.28 |
0.12 |
| Research and Development
Expenses |
$36.06 M
|
$26.81 M
|
$22.30 M
|
$18.83 M
|
$19.87 M
|
$13.66 M
|
$14.96 M
|
$15.64 M
|
| General & Administrative
Expenses |
$119.55 M
|
$51.69 M
|
$38.28 M
|
$24.19 M
|
$21.52 M
|
$12.32 M
|
$7.61 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$18.21 M
|
$8.60 M
|
$931,000.00
|
$2.07 M
|
$1.02 M
|
$674,000.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$119.55 M
|
$69.90 M
|
$38.28 M
|
$24.19 M
|
$23.60 M
|
$12.32 M
|
$7.61 M
|
$8.12 M
|
| Other Expenses |
$0.00 |
-$1.00 M |
-$877,000.00 |
$1.65 M |
$790,000.00 |
-$213,000.00 |
$548,000.00 |
$5,000.00 |
| Operating Expenses |
$182.82 M |
$96.71 M |
$60.59 M |
$43.02 M |
$43.47 M |
$25.97 M |
$22.56 M |
$23.75 M |
| Cost And Expenses |
$270.35 M |
$124.90 M |
$69.69 M |
$52.02 M |
$53.21 M |
$33.25 M |
$28.11 M |
$29.20 M |
| Interest Income |
$12.50 M |
$900,000.00 |
$100,000.00 |
$700,000.00 |
$1.00 M |
$0.00 |
$548,000.00 |
$5,000.00 |
| Interest Expense |
$10.79 M |
$3.73 M |
$3.87 M |
$3.99 M |
$4.35 M |
$2.42 M |
$1.07 M |
$979,000.00 |
| Depreciation &
Amortization |
$8.18 M
|
$4.20 M
|
$2.65 M
|
$1.58 M
|
$1.22 M
|
$769,000.00
|
$630,000.00
|
$426,000.00
|
| EBITDA |
-$7.60 M
|
-$28.96 M
|
-$38.49 M
|
-$23.15 M
|
-$27.93 M
|
-$20.23 M
|
-$19.09 M
|
-$22.66 M
|
| EBITDA Ratio |
-0.03 |
-0.35 |
-1.33 |
-0.96 |
-1.22 |
-1.51 |
-2.5 |
-3.63 |
| Operating Income Ratio
|
-0.12
|
-0.34
|
-1.3
|
-1.03
|
-1.25
|
-1.55
|
-2.66
|
-3.7
|
| Total Other
Income/Expenses Net |
$2.06 M
|
-$4.73 M
|
-$4.75 M
|
-$2.33 M
|
-$3.90 M
|
-$3.48 M
|
-$365,000.00
|
-$1.08 M
|
| Income Before Tax |
-$26.67 M |
-$36.17 M |
-$44.18 M |
-$28.72 M |
-$33.51 M |
-$23.72 M |
-$20.79 M |
-$24.07 M |
| Income Before Tax Ratio
|
-0.11
|
-0.39
|
-1.46
|
-1.12
|
-1.42
|
-1.82
|
-2.71
|
-3.88
|
| Income Tax Expense |
-$1.64 M |
$66,000.00 |
$36,000.00 |
$32,000.00 |
$40,000.00 |
$41,000.00 |
$32,000.00 |
$984,000.00 |
| Net Income |
-$25.03 M |
-$36.23 M |
-$44.22 M |
-$28.75 M |
-$33.55 M |
-$23.76 M |
-$20.82 M |
-$24.07 M |
| Net Income Ratio |
-0.1 |
-0.39 |
-1.46 |
-1.12 |
-1.42 |
-1.82 |
-2.71 |
-3.88 |
| EPS |
-0.77 |
-1.23 |
-1.6 |
-1.16 |
-2.36 |
-1.23 |
-1.44 |
-1.66 |
| EPS Diluted |
-0.77 |
-1.23 |
-1.6 |
-1.16 |
-2.36 |
-1.23 |
-1.44 |
-1.66 |
| Weighted Average Shares
Out |
$32.52 M
|
$29.56 M
|
$27.62 M
|
$24.70 M
|
$14.20 M
|
$19.25 M
|
$14.48 M
|
$14.48 M
|
| Weighted Average Shares
Out Diluted |
$32.52 M
|
$29.56 M
|
$27.62 M
|
$24.70 M
|
$14.20 M
|
$19.25 M
|
$14.48 M
|
$14.48 M
|
| Link |
|
|
|
|
|
|
|
|
